Blis takes out National Marketing Award
Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9012, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
23 September 2019
Blis takes out National Marketing Award
Dunedin based Blis Technologies walked away with the Health and Beauty sector award at the 2019
TVNZ New Zealand Marketing Awards held in Auckland earlier this month. Blis, in concert with their
advertising agency, Insight NZ Limited entered ThroatGuard PRO into the awards competing with
entries from other notable companies including the other finalist in the category Fisher & Paykel
Healthcare.
Blis has been working with its appointed agency, Insight NZ Limited on a brand campaign to lift
awareness and understanding of the novel ThroatGuard PRO proposition resulting in the brand
establishing itself as the number 1 product in the Throat Lozenge Category in pharmacies. Chief
Marketing Officer, Julie Curphey, said “it’s been three years of hard work from the wider Blis team
and this is fantastic recognition of that effort. It’s been a real team effort with our advertising
partners, Insight and our distribution partners, Radiant Health. This award is also evidence of the
transition we have made as a company from a strong science heritage to a company focused on the
effective commercialisation of that science”.
Ends
For further information, please contact:
Julie Curphey
Chief Marketing Officer
+64 21 344 527
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation
with evidence-based research and the highest quality production controls enables the delivery of probiotic
solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and
gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More
information about Blis Technologies Ltd can be found at www.blis.co.nz.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: Cxbladder included in the NCCN Bladder Cancer Guidelines2019-07-15
“Company Announcement 15 July 2019 CXBLADDER INCLUDED IN THE LATEST NCCN BLADDER CANCER GUIDELINES IN THE USA Cancer diagnostics company, Pacific Edge (NZX: PEB), advises that Cxbladder has been included in the latest version of the National Comprehensive Cancer Network…”
- PEB — Pacific Edge Limited: Pacific Edge FY20 Interim Results and Capital Raising2019-11-20
“Company Announcement 21 November 2019 6 The USA remains the primary commercial opportunity for Pacific Edge, with a growing number of very large and reputable healthcare providers and academic centres such as Johns Hopkins Medicine, Cleveland Clinic and Moun…”
- PEB — Pacific Edge Limited: Annual Report & Shareholder Letter2019-06-27
“CEO’S REPORT A major highlight in FY19 has been the commercial breakthrough seen in New Zealand, with Cxbladder now in use by the majority of the national public healthcare providers and, in some cases, being incorporated into their clinical guidelines, replacing the gold st…”